KR20050057245A - 남성 발기 부전을 치료하는 방법 - Google Patents

남성 발기 부전을 치료하는 방법 Download PDF

Info

Publication number
KR20050057245A
KR20050057245A KR1020057003891A KR20057003891A KR20050057245A KR 20050057245 A KR20050057245 A KR 20050057245A KR 1020057003891 A KR1020057003891 A KR 1020057003891A KR 20057003891 A KR20057003891 A KR 20057003891A KR 20050057245 A KR20050057245 A KR 20050057245A
Authority
KR
South Korea
Prior art keywords
composition
prostaglandin
patients
patient
mixtures
Prior art date
Application number
KR1020057003891A
Other languages
English (en)
Korean (ko)
Inventor
제임스 엘. 예이거
나디르 부육팀킨
서벳 부육팀킨
Original Assignee
넥스메드 홀딩스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/236,485 external-priority patent/US7105571B2/en
Application filed by 넥스메드 홀딩스 인코포레이티드 filed Critical 넥스메드 홀딩스 인코포레이티드
Publication of KR20050057245A publication Critical patent/KR20050057245A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020057003891A 2002-09-06 2003-09-05 남성 발기 부전을 치료하는 방법 KR20050057245A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/236,485 US7105571B2 (en) 2000-01-10 2002-09-06 Prostaglandin compositions and methods of treatment for male erectile dysfunction
US10/236,485 2002-09-06
US48327803P 2003-06-27 2003-06-27
US60/483,278 2003-06-27

Publications (1)

Publication Number Publication Date
KR20050057245A true KR20050057245A (ko) 2005-06-16

Family

ID=31980977

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057003891A KR20050057245A (ko) 2002-09-06 2003-09-05 남성 발기 부전을 치료하는 방법

Country Status (10)

Country Link
EP (1) EP1534297A1 (fr)
JP (1) JP2006512291A (fr)
KR (1) KR20050057245A (fr)
CN (1) CN1674912A (fr)
AU (1) AU2003273291A1 (fr)
CA (1) CA2493723A1 (fr)
EA (1) EA200500452A1 (fr)
IL (1) IL166273A0 (fr)
NO (1) NO20050658L (fr)
WO (1) WO2004022064A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
JP2006520788A (ja) * 2003-03-21 2006-09-14 ネックスメド ホールディングス インコーポレイテッド プロスタグランジン組成物による血管形成促進および方法
MXPA05010069A (es) * 2003-03-21 2005-11-23 Nexmed Holdings Inc Composiciones de prostaglandina para el tratamiento de la disfuncion erectil.
EP3266458A1 (fr) 2016-07-05 2018-01-10 Fagron B.V. Procédé et composition et kit pour traiter un dysfonctionnement érectile

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
WO2003070281A1 (fr) * 2002-02-15 2003-08-28 Nexmed (Holdings), Inc. Composition de prostaglandine pour le traitement des troubles de l'erection

Also Published As

Publication number Publication date
CN1674912A (zh) 2005-09-28
JP2006512291A (ja) 2006-04-13
EP1534297A1 (fr) 2005-06-01
NO20050658L (no) 2005-04-01
EA200500452A1 (ru) 2005-10-27
AU2003273291A1 (en) 2004-03-29
CA2493723A1 (fr) 2004-03-18
WO2004022064A1 (fr) 2004-03-18
IL166273A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
US6323241B1 (en) Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) Prostaglandin compositions and methods of treatment for male erectile dysfunction
KR101086147B1 (ko) 조루증 치료용 조성물 및 치료 방법
US11246932B2 (en) Prostaglandin compositions and methods for the treatment of vasospasm
AU2002323650A1 (en) Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) Prostaglandin compositions and methods of treatment for male erectile dysfunction
US20030220292A1 (en) Treatment of erectile dysfunction
US20040110843A1 (en) Methods of treatment of male erectile dysfunction
KR20050057245A (ko) 남성 발기 부전을 치료하는 방법
KR20050119136A (ko) 프로스타글란딘 조성물에 의한 혈관형성 촉진 및 방법
TW200407149A (en) Methods of treatment of male erectile dysfunction

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid